Bactolife A/S
Public limited companyCVR 38879073København ØActive
Bactolife A/S is a public limited company, based in København Ø, active in manufacture of other chemical products n.e.c., founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 74m. With 51 employees, the company is about 4 times larger than the industry median. Equity grew to DKK 203.7m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss grew: from DKK 49.2m to DKK 74m (2024 → 2025).
- Equity rose 25% (2024 → 2025), to DKK 203.7m.
Employees
- 1 fewer employees than a year earlier: 51 (07/2026) against 52 (07/2025).
Management and owners, last 24 months
- New in management: Sara Sande (board member, 19/12/2025), Sophia Andrea Helga Heyde (board member, 19/12/2025) and Donna Margaret Parr (board member, 19/12/2025).
- Stepped down: Morten Aleksandr Engel (board member, 19/12/2025).
- New owners registered: MR Bioinvest ApS (30/12/2025), Novo Holdings A/S (30/12/2025) and Selfinvest ApS (30/12/2025) (+3).
- No longer registered as owner: MR Bioinvest ApS (29/12/2025), Novo Holdings A/S (29/12/2025) and Selfinvest ApS (29/12/2025) (+5).
Registrations, last 24 months
- 09/06/2026: Share capital changed from 1,074,533 DKK to 1,113,447 DKK
- 19/12/2025: Share capital changed from 809,047 DKK to 1,074,533 DKK
- 01/01/2025: Industry changed to Manufacture of other chemical products n.e.c. (205900)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | 1,484 | 333 | 0 | not stated | not stated | – |
| Gross profit | −1,306 | −2,075 | −9,117 | −16,794 | −21,682 | −36,029 | −66.2% |
| Operating profit (EBIT) | −3,786 | −10,691 | −28,810 | −47,623 | −59,198 | −81,095 | −37% |
| Profit before tax | −3,884 | −10,817 | −31,845 | −51,081 | −54,729 | −79,505 | −45.3% |
| Net profit | −2,717 | −8,224 | −27,568 | −45,581 | −49,229 | −74,005 | −50.3% |
| Total assets | 9,642 | 57,513 | 84,338 | 232,625 | 175,931 | 221,825 | +26.1% |
| Equity | 6,938 | 51,457 | 23,889 | 211,744 | 162,515 | 203,677 | +25.3% |
| Liabilities | 2,704 | 5,714 | 60,048 | 19,830 | 11,872 | 15,522 | +30.7% |
| Cash and cash equivalents | 7,575 | 44,185 | 68,940 | 202,237 | 142,439 | 187,402 | +31.6% |
| Average number of employees | 2 | 8 | – | 32 | 40 | 44 | +10% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 22/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 11/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 10/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 30/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 13/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 10/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
29 companies in the databaseComparison with the other companies in manufacture of other chemical products n.e.c. based on the latest financial year.
Industry median: gross profit DKK 13.6m, net profit DKK 2.4m, equity DKK 16.4m, 14 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 50–199 employees4,467 companies in the comparison | No. 4,397of 4,412 Better than 0% | No. 336of 4,466 Better than 92% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 33,566of 33,588 Better than 0% | No. 403of 33,687 Better than 99% |
| All companies of type A/S18,025 companies in the comparison | No. 17,752of 17,786 Better than 0% | No. 1,418of 18,024 Better than 92% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of other chemical products n.e.c.- Bactolife A/S−DKK 36m
- Chr. Hansen A/SDKK 4.4bn
- International N&H Denmark ApSDKK 889m
- Bactolife A/S−DKK 74m
- Chr. Hansen A/SDKK 2.1bn
- International N&H Denmark ApSDKK 1.4bn
- Bactolife A/SDKK 203.7m
- Chr. Hansen A/SDKK 11.3bn
- International N&H Denmark ApSDKK 4.2bn
- Bactolife A/S51
- Chr. Hansen A/S1,747
- International N&H Denmark ApS1,022
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- MR Bioinvest ApS5%
- Novo Holdings A/S20%
- Selfinvest ApS5%
- Danmarks Eksport- og Investeringsfond5%
- ATHOS Biopharma GmbH20%
- Gates Foundation10%
Management
8 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Claus Sebastian Søderberg | CEO | 01/01/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jørgen Rugholm Jensen | Chair of the board | 25/05/2021 |
| Mads Aage Laustsen | Board member | 04/08/2023 |
| Frank Julian Zachmann | Board member | 04/08/2023 |
| Rhonda Doyce Hoffman | Board member | 03/10/2023 |
| Sara Sande | Board member | 19/12/2025 |
| Sophia Andrea Helga Heyde | Board member | 19/12/2025 |
| Donna Margaret Parr | Board member | 19/12/2025 |
- Founders
- Laustsen Ventures ApS
Former management (8)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Mads Aage Laustsen | Board member | 10/08/2017 | 09/04/2021 |
| Mads Aage Laustsen | Director | 10/08/2017 | 01/01/2023 |
| Andreas Hougaard Laustsen-Kiel | Board member | 10/08/2017 | 09/04/2021 |
| Per Falholt | Board member | 10/08/2017 | 04/08/2023 |
| David Carl Christian von Kauffmann | Chair of the board | 10/08/2017 | 09/04/2021 |
| Morten Jensen | Board member | 09/04/2021 | 25/05/2021 |
| Morten Aleksandr Engel | Board member | 09/04/2021 | 19/12/2025 |
| Claus Sebastian Søderberg | Director | 01/04/2022 | 31/12/2022 |
Signing rule: Selskabet tegnes af en direktør og bestyrelsesformanden, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Address and production units
1 active production unitsRønnegade 8
2100 København Ø
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Bactolife A/S | Rønnegade 8, 2, 2100 København Ø | 52 | 1027655633 |
Purpose
Selskabets formål er udvikling af produkter rettet mod smitsomme sygdomme og anden forretningsmæssig aktivitet beslægtet hermed.
The purpose is quoted from the register in Danish.
Changes year by year
103 registered events20264 changesaccounts 1 · capital 1 · ownership 2
- AccountsAnnual report for 2025 published
- CapitalShare capital changed from 1,074,533 DKK to 1,113,447 DKK
- OwnershipGates Foundation registered as owner (10%)
- OwnershipGates Foundation is no longer registered as owner
202519 changesownership 12 · capital 1 · management 4 · accounts 1 · industry 1
- OwnershipMR BIOINVEST ApS registered as owner (5%)
- OwnershipNovo Holdings A/S registered as owner (20%)
- OwnershipATHOS Biopharma GmbH registered as owner (20%)
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (5%)
- OwnershipSELFINVEST ApS registered as owner (5%)
- OwnershipNOVOZYMES A/S is no longer registered as owner
- OwnershipLAUSTSEN VENTURES ApS is no longer registered as owner
- OwnershipLILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
- OwnershipATHOS Biopharma GmbH is no longer registered as owner
- OwnershipMR BIOINVEST ApS is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipSELFINVEST ApS is no longer registered as owner
- CapitalShare capital changed from 809,047 DKK to 1,074,533 DKK
- ManagementDonna Margaret Parr appointed board member
- ManagementSophia Andrea Helga Heyde appointed board member
- ManagementSara Sande appointed board member
- ManagementMorten Aleksandr Engel stepped down as board member
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Manufacture of other chemical products n.e.c. (205900)
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
202323 changesmanagement 6 · capital 1 · ownership 15 · accounts 1
- ManagementRhonda Doyce Hoffman appointed board member
- CapitalShare capital changed from 400,001 DKK to 809,047 DKK
- ManagementMads Aage Laustsen appointed board member
- ManagementFrank Julian Zachmann appointed board member
- ManagementPer Falholt stepped down as board member
- OwnershipNOVOZYMES A/S registered as owner (5%)
- OwnershipATHOS Biopharma GmbH registered as owner (20%)
- OwnershipGates Foundation registered as owner (5%)
- OwnershipLAUSTSEN VENTURES ApS registered as owner (5%)
- OwnershipLILLE FREDERIKSLUND INVEST ApS registered as owner (5%)
- OwnershipMR BIOINVEST ApS registered as owner (5%)
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipSELFINVEST ApS registered as owner (5%)
- OwnershipEEP CO-Investment Ltd. is no longer registered as owner
- OwnershipLAUSTSEN VENTURES ApS is no longer registered as owner
- OwnershipMR BIOINVEST ApS is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipSELFINVEST ApS is no longer registered as owner
- OwnershipNOVOZYMES A/S is no longer registered as owner
- OwnershipLILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
- AccountsAnnual report for 2022 published
- ManagementClaus Sebastian Søderberg appointed ceo
- ManagementMads Aage Laustsen stepped down as director
20226 changesmanagement 2 · address 1 · accounts 1 · name 1 · capital 1
- ManagementClaus Sebastian Søderberg stepped down as director
- AddressMoved to Rønnegade 8, 2, 2100 København Ø
- AccountsAnnual report for 2021 published
- NameName changed from Bactolife ApS to Bactolife A/S
- CapitalShare capital changed from 390,780 DKK to 400,001 DKK
- ManagementClaus Sebastian Søderberg appointed director
202125 changesaddress 1 · capital 2 · accounts 1 · management 7 · ownership 14
- AddressMoved to Lersø Parkallé 38, 2, 2100 København Ø
- CapitalShare capital changed from 388,093 DKK to 390,780 DKK
- AccountsAnnual report for 2020 published
- ManagementJørgen Rugholm Jensen appointed chair of the board
- ManagementMorten Jensen stepped down as board member
- CapitalShare capital changed from 248,240 DKK to 388,093 DKK
- ManagementMorten Aleksandr Engel appointed board member
- ManagementMorten Jensen appointed board member
- ManagementAndreas Hougaard Laustsen-Kiel stepped down as board member
- ManagementDavid Carl Christian von Kauffmann stepped down as chair of the board
- ManagementMads Aage Laustsen stepped down as board member
- OwnershipLAUSTSEN VENTURES ApS registered as owner (10%)
- OwnershipMR BIOINVEST ApS registered as owner (15%)
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipSELFINVEST ApS registered as owner (10%)
- OwnershipNOVOZYMES A/S registered as owner (5%)
- OwnershipLILLE FREDERIKSLUND INVEST ApS registered as owner (10%)
- OwnershipEEP CO-Investment Ltd. registered as owner (5%)
- OwnershipEEP CO-Investment Ltd. is no longer registered as owner
- OwnershipLAUSTSEN VENTURES ApS is no longer registered as owner
- OwnershipNOVOZYMES A/S is no longer registered as owner
- OwnershipLILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
- OwnershipMR BIOINVEST ApS is no longer registered as owner
- OwnershipEEP CO-Investment Ltd. registered as owner (10%)
- OwnershipDavid Carl Christian von Kauffmann is no longer registered as owner
20205 changescapital 1 · ownership 3 · address 1
- CapitalShare capital changed from 202,922 DKK to 248,240 DKK
- OwnershipLAUSTSEN VENTURES ApS registered as owner (15%)
- OwnershipSandra Wingaard Thrane is no longer registered as owner
- OwnershipLAUSTSEN VENTURES ApS is no longer registered as owner
- AddressMoved to Diplomvej 381, 2800 Kongens Lyngby
20186 changescapital 1 · ownership 5
- CapitalShare capital changed from 178,571 DKK to 202,922 DKK
- OwnershipDavid Carl Christian von Kauffmann registered as owner (10%)
- OwnershipLAUSTSEN VENTURES ApS registered as owner (20%)
- OwnershipNOVOZYMES A/S registered as owner (10%)
- OwnershipDavid Carl Christian von Kauffmann is no longer registered as owner
- OwnershipLAUSTSEN VENTURES ApS is no longer registered as owner
201714 changescapital 3 · ownership 5 · founded 1 · management 5
- CapitalShare capital changed from 150,000 DKK to 178,571 DKK
- OwnershipDavid Carl Christian von Kauffmann registered as owner (15%)
- OwnershipSandra Wingaard Thrane registered as owner (5%)
- CapitalShare capital changed from 116,071 DKK to 150,000 DKK
- OwnershipLILLE FREDERIKSLUND INVEST ApS registered as owner (15%)
- CapitalShare capital changed from 50,000 DKK to 116,071 DKK
- OwnershipMR BIOINVEST ApS registered as owner (25%)
- FoundedRegistered as Bactolife ApS
- ManagementPer Falholt appointed board member
- ManagementAndreas Hougaard Laustsen-Kiel appointed board member
- ManagementMads Aage Laustsen appointed director
- ManagementDavid Carl Christian von Kauffmann appointed chair of the board
- ManagementMads Aage Laustsen appointed board member
- OwnershipLAUSTSEN VENTURES ApS registered as owner (25%)
Related companies
Same people in management
- Novozymes A/Svia Per Falholt
- Danfoss A/Svia Per Falholt
- AGC Biologics A/Svia Mads Aage Laustsen
- Accura Advokatpartnerselskabvia Morten Jensen
- Bruun & Hjejle Advokatpartnerselskabvia Morten Jensen
- Co-ro A/Svia Per Falholt
Largest in the industry
- Chr. Hansen A/SDKK 4.4bn
- International N&H Denmark ApSDKK 889m
- Palsgaard A/SDKK 690.7m
- Daka Denmark A/SDKK 299.7m
- Brenntag Nordic A/SDKK 273.2m
- LGC Biosearch Technologies A/SDKK 53.4m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.